
Flomyst F(250 mcg+1
Beximco Pharmaceuticals Ltd.
Fluticasone Propionate + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) and more.
Fluticasone Propionate + Formoterol Fumarate is a fixed-dose combination inhaler containing an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA), indicated for the regular maintenance treatment of asthma in adults and adolescents (12 years and older) in whom use of a combination inhaler is appropriate, specifically:
Fluticasone Propionate + Formoterol Fumarate is a maintenance (controller) therapy and is not indicated for the relief of acute bronchospasm or as a rescue treatment for sudden asthma attacks; a separate short-acting bronchodilator should always be available for acute symptoms.
Evidence supporting use of Fluticasone Propionate + Formoterol Fumarate in chronic obstructive pulmonary disease (COPD) is limited, and this specific combination is generally not recommended for COPD; it should be used in COPD only under specific physician direction where locally approved.
Dosing of Fluticasone Propionate + Formoterol Fumarate is individualized according to asthma severity and prior therapy, using the lowest strength that maintains control.
| Population | Recommended Dose |
|---|---|
| Adults and adolescents 12 years and older | Two inhalations twice daily (morning and evening, about 12 hours apart), using the strength (50/5, 125/5, or 250/10 mcg) appropriate to asthma severity. |
| Children under 12 years | Not recommended; safety and efficacy have not been established in this age group. |
The 250/10 mcg strength is intended for adults only. Fluticasone Propionate + Formoterol Fumarate should be used at regular intervals exactly as prescribed, even when asymptomatic, and must not be stopped abruptly or the dose changed without medical advice. If symptoms occur between doses, a separate fast-acting rescue inhaler should be used; increasing rescue-inhaler use requires medical review. See Administration below for correct inhaler technique and mouth-rinsing instructions.
Side effects associated with Fluticasone Propionate + Formoterol Fumarate may include:
Patients should seek prompt medical attention for signs of a serious allergic reaction, sudden worsening of breathing after a dose, chest pain/palpitations, or visual disturbance.
Fluticasone Propionate + Formoterol Fumarate is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.